AVDL Avadel Pharmaceuticals plc Ordinary Share PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

AVDL Stock Analysis: Buy, Sell, or Hold?

$21.64
+0.01 (+0.05%) ▲
5d: +0.32% 30d: +0.65% 90d: +15.72%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
48/100
Position
FAIR
Forward P/E & Valuation
28.8x FAIR
vs 27.4x historical avg
Wall Street Target
$20.94
-3.2% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$21.54 / $21.76
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: AVDL is fairly priced but lacks strong directional signals. At 1.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.

Get Alerted When AVDL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$36.55
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.70
4.7% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AVDL is currently trading at $21.64, which is considered fair based on recent price action. The stock's valuation (Forward PE: 28.8) is in line with its historical norms (27.4). At these levels, the market is pricing in 1.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, AVDL is in a strong uptrend. The price is currently testing key support at $21.54. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: AVDL scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 48/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 74.8%

Trading Range & Key Levels

Support Level $21.54
Resistance Level $21.76
Current Trend Strong Uptrend
Technical data as of Feb 11, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (75/100)
  • NEUTRAL: Near Wall St target ($20.94)
  • NEUTRAL: Market pricing in 1.6% annual earnings growth - fairly valued
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 28.82
Wall Street Target $20.94 (-3.2%)
Revenue Growth (YoY) 54.9%
Profit Margin -0.1%
Valuation Premium vs History +1.6% premium
PE vs Historical 28.8 vs 27.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.6% (market-implied from PE analysis)
1-Year Target $21.99 (+2%)
2-Year Target $22.34 (+3%)
3-Year Target $22.70 (+5%)
3-Yr Target (if PE normalizes) (PE: 29→27) PE COMPRESSION $21.58 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 28.8, Growth: 282.5%) $73.03 (+238%)
Base: (SPY PE: 22.5, Growth: 282.5%) $57.12 (+164%)
Bear: (PE: 19.2, Growth: 282.5%) $48.55 (+124%)
Share AVDL Analysis

Share this live AVDL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (AVDL)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Feb 17, 2026
Daily AI digest
AI Retail Discussion Summary: Qube Research & Technologies Limited disclosed interests and short positions in Avadel Pharmaceuticals plc in an Irish Takeover Panel Opening Position Disclosure, representing 1.18% of the company's $0.01 ordinary shares.
Key Retail Themes: Mandatory disclosure of interests and short positions under Irish Takeover Panel rules Avadel Pharmaceuticals plc - ownership structure
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 4:51 AM ET
Data refreshes hourly during market hours. Next update: 5:51 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AVDL.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences Iâ€Ļ
STRONG BUY
28 analysts
$208 39 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 42 HOLD
UTHR
United Therapeutics Corpâ€Ļ
STRONG BUY
15 analysts
$687 54 HOLD
ELAN
Elanco Animal Health
STRONG BUY
16 analysts
$31 47 HOLD
AQST
Aquestive Therapeutics Iâ€Ļ
STRONG BUY
9 analysts
$9 62 BUY
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals